Multicenter cohort study on the relation between soluble PD-L1 and prognosis of age-related EBV-associated lymphoproliferative disorders.

Multicenter cohort study on the relation between soluble PD-L1 and prognosis of age-related EBV-associated lymphoproliferative disorders. - The relation between soluble PD-L1 and prognosis of age-related EBV-associated lymphoproliferative disorders

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000022932

Enrollment

Registered

2016-07-15

Start date

2016-07-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

EBV-associated diffuse large B-cell lymphoma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) The cases were diagnosed as DLBCL, which is defined by WHO classification 4th ed. 2008 and which is EBER positive using immunostaining. 2) 15 samples were prepared for central review by a pathologist. 3) The patients voluntarily gave written consent to participate in the study.

Exclusion criteria

Exclusion criteria: The cases were diagnosed as immunodeficiency-associated lymphoproliferative disorders, which are defined by WHO classification 4th ed. 2008.

Design outcomes

Primary

Measure	Time frame
To determine the relation between soluble PD-L1 and IPI in EBV-associated LPD.	—

Countries

Japan

Contacts

Public ContactAkane Kunitomi

National Hospital Organization Nagoya Medical Center Department of Hematology

akunitom@nnh.hosp.go.jp052-951-1111

Outcome results